Brief: ICMR Empanels Dr. Lal Pathlabs' Rohini, New Delhi Lab For COVID-19 Testing
24/03/2020 05:59
March 24 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* INDIAN COUNCIL OF MEDICAL RESEARCH HAS EMPANELLED CO'S
NATIONAL
REFERENCE LAB AT ROHINI, NEW DELHI FOR COVID-19 TESTING
Source text for Eikon: ID:nBSE7dZbvp
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise